The Journal of Toxicological Sciences
暂无分享,去创建一个
[1] E. Rajnavölgyi,et al. Effects of RAMEA-complexed polyunsaturated fatty acids on the response of human dendritic cells to inflammatory signals , 2014, Beilstein journal of organic chemistry.
[2] G. Dubini,et al. Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation , 2014, Proceedings of the National Academy of Sciences.
[3] L. Szente,et al. Cyclodextrins, blood-brain barrier, and treatment of neurological diseases. , 2014, Archives of medical research.
[4] Tamás Sohajda,et al. Ionization States, Cellular Toxicity and Molecular Modeling Studies of Midazolam Complexed with Trimethyl-β-Cyclodextrin , 2014, Molecules.
[5] G. Crini,et al. Review: a history of cyclodextrins. , 2014, Chemical reviews.
[6] Anna Tourovskaia,et al. Tissue-engineered microenvironment systems for modeling human vasculature , 2014, Experimental biology and medicine.
[7] Duc-Huy T Nguyen,et al. Fluid shear stress threshold regulates angiogenic sprouting , 2014, Proceedings of the National Academy of Sciences.
[8] O. B. Usta,et al. Dynamic interplay of flow and collagen stabilizes primary hepatocytes culture in a microfluidic platform. , 2014, Lab on a chip.
[9] Shili Yan,et al. Hepatocyte cocultures with endothelial cells and fibroblasts on micropatterned fibrous mats to promote liver-specific functions and capillary formation capabilities. , 2014, Biomacromolecules.
[10] Benjamin Rappaz,et al. Digital Holographic Microscopy: A Quantitative Label-Free Microscopy Technique for Phenotypic Screening , 2014, Combinatorial chemistry & high throughput screening.
[11] D. Ingber,et al. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. , 2013, Integrative biology : quantitative biosciences from nano to macro.
[12] A. Goetz,et al. Changes in sevoflurane plasma concentration with delivery through the oxygenator during on-pump cardiac surgery. , 2013, British journal of anaesthesia.
[13] Michiya Matsusaki,et al. Multilayered Blood Capillary Analogs in Biodegradable Hydrogels for In Vitro Drug Permeability Assays , 2013 .
[14] Hyunjae Lee,et al. Engineering of functional, perfusable 3D microvascular networks on a chip. , 2013, Lab on a chip.
[15] G. Turcatti,et al. Label-free cytotoxicity screening assay by digital holographic microscopy. , 2013, Assay and drug development technologies.
[16] Daniel C Leslie,et al. A Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice , 2012, Science Translational Medicine.
[17] N. Parinandi,et al. Choice of cyclodextrin for cellular cholesterol depletion for vascular endothelial cell lipid raft studies: cell membrane alterations, cytoskeletal reorganization and cytotoxicity. , 2012, Indian journal of biochemistry & biophysics.
[18] Holger Gohlke,et al. MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. , 2012, Journal of chemical theory and computation.
[19] Despina Bazou,et al. Anastomosis of endothelial sprouts forms new vessels in a tissue analogue of angiogenesis. , 2012, Integrative biology : quantitative biosciences from nano to macro.
[20] Noo Li Jeon,et al. In vitro formation and characterization of a perfusable three-dimensional tubular capillary network in microfluidic devices. , 2012, Lab on a chip.
[21] C. Förster,et al. α-Cyclodextrin dimer complexes of dopamine and levodopa derivatives to assess drug delivery to the central nervous system: ADME and molecular docking studies , 2012, International journal of nanomedicine.
[22] Ali Khademhosseini,et al. SAM-based cell transfer to photopatterned hydrogels for microengineering vascular-like structures. , 2011, Biomaterials.
[23] Lance L. Munn,et al. Fluid forces control endothelial sprouting , 2011, Proceedings of the National Academy of Sciences.
[24] Cesar A. López,et al. Molecular Mechanism of Cyclodextrin Mediated Cholesterol Extraction , 2011, PLoS Comput. Biol..
[25] T. Kiss,et al. Evaluation of the cytotoxicity of beta-cyclodextrin derivatives: evidence for the role of cholesterol extraction. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[26] D. Ingber,et al. Reconstituting Organ-Level Lung Functions on a Chip , 2010, Science.
[27] T. Loftsson,et al. Cyclodextrins as solubilizers: formation of complex aggregates. , 2010, Journal of pharmaceutical sciences.
[28] T. Kiss,et al. P-glycoprotein inhibition by membrane cholesterol modulation. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[29] Nuria Sanvicens,et al. Multifunctional nanoparticles--properties and prospects for their use in human medicine. , 2008, Trends in biotechnology.
[30] Rhiju Das,et al. Macromolecular modeling with rosetta. , 2008, Annual review of biochemistry.
[31] W. D. de Jong,et al. Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.
[32] T. Kiss,et al. Cytotoxicity of different types of methylated beta-cyclodextrins and ionic derivatives. , 2007, Die Pharmazie.
[33] Joe Tien,et al. Fabrication of microfluidic hydrogels using molded gelatin as a sacrificial element. , 2007, Lab on a chip.
[34] Raphael Zidovetzki,et al. Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. , 2007, Biochimica et biophysica acta.
[35] C. Förster,et al. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli , 2006, Journal of Neuroimmunology.
[36] Y. Henis,et al. Cyclodextrins but not Compactin Inhibit the Lateral Diffusion of Membrane Proteins Independent of Cholesterol , 2006, Traffic.
[37] Joe Tien,et al. Formation of perfused, functional microvascular tubes in vitro. , 2006, Microvascular research.
[38] Holger Gohlke,et al. The Amber biomolecular simulation programs , 2005, J. Comput. Chem..
[39] H. Heerklotz,et al. Interactions of cholesterol with lipid membranes and cyclodextrin characterized by calorimetry. , 2005, Biophysical journal.
[40] C. Förster,et al. Occludin as direct target for glucocorticoid‐induced improvement of blood–brain barrier properties in a murine in vitro system , 2005, The Journal of physiology.
[41] M. Másson,et al. Cyclodextrins in drug delivery , 2005, Expert opinion on drug delivery.
[42] Hidetoshi Arima,et al. Contribution of Cholesterol and Phospholipids to Inhibitory Effect of Dimethyl-β-Cyclodextrin on Efflux Function of P-Glycoprotein and Multidrug Resistance-Associated Protein 2 in Vinblastine-Resistant Caco-2 Cell Monolayers , 2004, Pharmaceutical Research.
[43] E. Wawrousek,et al. Expression and induction of the stress protein alpha-B-crystallin in vascular endothelial cells , 2002, Histochemistry and Cell Biology.
[44] P Smith,et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.
[45] M. Másson,et al. Effect of cyclodextrins and polymers on triclosan availability and substantivity in toothpastes in vivo. , 1999, Journal of pharmaceutical sciences.
[46] F. Hirayama,et al. Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity. , 1999, Journal of pharmaceutical sciences.
[47] Matsuda,et al. Cyclodextrins in transdermal and rectal delivery. , 1999, Advanced drug delivery reviews.
[48] B. Mikami,et al. Crystal Structure of Recombinant Soybean β-Amylase Complexed with β-Cyclodextrin* , 1998, The Journal of Biological Chemistry.
[49] William L. Jorgensen,et al. OPLS all‐atom force field for carbohydrates , 1997 .
[50] M C Phillips,et al. Use of cyclodextrins for manipulating cellular cholesterol content. , 1997, Journal of lipid research.
[51] K. Uekama,et al. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. , 1997, Journal of pharmaceutical sciences.
[52] T. Darden,et al. A smooth particle mesh Ewald method , 1995 .
[53] Kenneth D. Jordan,et al. Comparison of Density Functional and MP2 Calculations on the Water Monomer and Dimer , 1994 .
[54] P. Kollman,et al. Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models , 1992 .
[55] Y. Kubota,et al. Induction of morphologic differentiation of endothelial cells in culture. , 1989, The Journal of investigative dermatology.
[56] Lois Oakes,et al. HUMAN DISEASE , 1957, The Ulster Medical Journal.
[57] Brendon M. Baker,et al. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues , 2012 .
[58] Daniel C Leslie,et al. Dongeun Huh Lung-ona-Chip Microdevice Induced Pulmonary Edema in a − A Human Disease Model of Drug Toxicity , 2012 .
[59] S. Bhatia,et al. Microscale culture of human liver cells for drug development , 2008, Nature Biotechnology.
[60] M. N. Nakatsu,et al. An optimized three-dimensional in vitro model for the analysis of angiogenesis. , 2008, Methods in enzymology.
[61] S. Gould,et al. 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[62] P. Newberne,et al. Safety assessment of gamma-cyclodextrin. , 2004, Regulatory toxicology and pharmacology : RTP.
[63] C. Turner,et al. JCB Article , 2001 .
[64] K. Uekama,et al. Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes. , 1989, European journal of biochemistry.